Shining light on orphan receptors

Light has been used for the first time to activate a receptor for which the compound binding and controlling it naturally is unknown, researchers suggests. A team of scientists has now employed its novel application of optogenetics to identify a new compound that inhibits the orphan receptor ROS1, which has been linked to several forms of cancer. (Mehr in: Cancer News — ScienceDaily)